Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A UK Perspective.

P Davey1

  • 1Department of Clinical Pharmacology, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland. p.g.davey@dundee.ac.uk

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|May 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Residual effect of community antimicrobial exposure on risk of hospital onset healthcare-associated Clostridioides difficile infection: a case-control study using national linked data.

The Journal of hospital infection·2019
Same author

Implementation of antibiotic stewardship in different settings - results of an international survey.

Antimicrobial resistance and infection control·2019
Same author

Using chiral ionic liquid additives to enhance asymmetric induction in a Diels-Alder reaction.

Dalton transactions (Cambridge, England : 2003)·2017
Same author

A Comparison of Asian and Global Pharmaceutical Prices Using an EKS Method.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Developing a Patient Centred Model for Clinicians to Individualise Cost Effective Treatment.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Differentiation of gluteus medius and minimus activity in weight bearing and non-weight bearing exercises by M-mode ultrasound imaging.

Manual therapy·2015
Same journal

Development and Validation of a Brief Healthcare Insecurity Scale in a Sample of U.S. Adults Living with and without HIV.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

A Competency Framework for Health Technology Assessment Expertise: Results from a Delphi Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Physician-led Switching from Reference Biologics to Biosimilars: What is the Effect on selected Health-Related Outcomes and Costs for IBD Patients in Germany?

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Critical Comments by the European Medicines Agency on Patient-Reported Outcomes in Regulatory Submissions (2020-2023).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Interpreting the Economic Value of TPEx in Recurrent or Metastatic HNSCC: The Importance of Decision Context, Utility Timing, and Treatment Burden.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Development, use and psychometric properties of vision and hearing bolt-ons for EQ-5D-3L and EQ-5D-5L: a systematic review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
See all related articles

Lipid-lowering treatment decisions in the UK are influenced by national policies, including rationing and cost containment. This analysis examines factors affecting cardiovascular disease prevention and statin prescription.

Area of Science:

  • Cardiovascular Disease Prevention
  • Health Policy and Management
  • Pharmacoeconomics

Background:

  • Lipid-lowering treatment decisions vary significantly across European countries due to diverse legislation.
  • Generalizing European policy on lipid management is challenging.
  • The United Kingdom's approach is influenced by specific healthcare economic factors.

Purpose of the Study:

  • To analyze the impact of UK-specific policies on lipid-lowering treatment decisions.
  • To discuss primary versus secondary prevention strategies for cardiovascular disease.
  • To review current recommendations for statin and other lipid-lowering interventions.

Main Methods:

  • Policy analysis from a United Kingdom perspective.
  • Examination of factors including rationing, cost containment, and fund-holding.

Related Experiment Videos

  • Review of clinical guidelines for cardiovascular disease prevention.

    • Main Results:

    • UK healthcare policy significantly impacts lipid-lowering treatment accessibility and prescribing.
    • Rationing, cost containment, and drug expenses are key considerations.
    • Divergence in national policies complicates a unified European approach.

    Conclusions:

    • Healthcare policy and economic factors critically shape lipid-lowering treatment strategies in the UK.
    • Tailored approaches are necessary due to variations in national legislation.
    • Effective cardiovascular disease prevention requires balancing clinical need with economic realities.